Vimarsana
Biggest News Aggregation in the World

Page 4 - Saving Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Saving Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Saving Access Today - Breaking & Trending Today

Medicare Cuts Could Limit Access to Critical Lab Tests - Vimarsana News

Medicare Cuts Could Limit Access to Critical Lab Tests

(NewsUSA) - Medical tests done by clinical laboratories are an essential part of health care. However, repeated Medicare reimbursement cuts to clinical laboratory services could threaten patients' access to common tests used to diagnose, monitor and ...

Key Medicare Issues to Watch in Lame Duck Session | Akin Gump Strauss Hauer & Feld LLP - Vimarsana News

Key Medicare Issues to Watch in Lame Duck Session | Akin Gump Strauss Hauer & Feld LLP

Washington, D.C. is currently focused on a September continuing resolution (CR) to keep the federal government funded, but it is worth looking ahead to the broader health care horizon...

Key Medicare Issues To Watch In Lame Duck Session - Healthcare - Vimarsana News

Key Medicare Issues To Watch In Lame Duck Session - Healthcare

Washington, D.C. is currently focused on a September continuing resolution (CR) to keep the federal government funded, but it is worth looking ahead to the broader health care horizon...

Source: mondaq.com
Lab Organizations Urge Congress to Pass SALSA Legislation to Reform PAMA - Vimarsana News

Lab Organizations Urge Congress to Pass SALSA Legislation to Reform PAMA

A group of more than 20 organizations sent Congress a letter calling for passage of the bill, which would delay payment cuts and change price data collection methods.

Source: 360dx.com
Second time's the charm for ALS drug candidate- POLITICO - Vimarsana News

Second time's the charm for ALS drug candidate- POLITICO

The FDA’s advisory committee on neurological drugs voted in favor of recommending the agency approve a novel amyotrophic lateral sclerosis drug candidate.